跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Tobrex
Approved
STANDARD
Tobrex
Alcon Research, Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a76d2715ab3b79e8
Company
Alcon Research, Ltd.
Type
Standard
Approval Details
Approval Id
a76d2715ab3b79e8
Drug Approval Philippines Name
Tobrex
Product Name
Tobrex
Registration Number
DR-XY7060
Brand Name
Tobrex
Generic Name
Tobramycin
Dosage Form
Sterile Ophthalmic Solution (eye Drops)
Dosage Strength
3 mg/mL (0.3% w/v)
Manufacturer
Alcon Research, Ltd.
Importer
Novartis Healthcare Philippines, Inc.
Company Detail Path
/organization/alcon-research-ltd
Issuance Date
11 August 2024
Expiry Date
25 October 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a76d2715ab3b79e8
Type
Standard
Back to Philippines FDA Approvals
Tobrex - Philippines FDA Drug Approval Details